GSK (GSK.L) stock price, revenue, and financials

GSK market cap is £68.2 b, and annual revenue was £33.75 b in FY 2019

£68.2 B

GSK.L Mkt cap, 07-May-2021

£8.6 B

GSK Revenue Q3, 2020
GSK Gross profit (Q3, 2020)5.8 B
GSK Gross profit margin (Q3, 2020), %66.6%
GSK Net income (Q3, 2020)1.4 B
GSK EBIT (Q3, 2020)1.9 B
GSK Cash, 30-Sept-20204.3 B
GSK EV92.2 B

GSK Revenue

GSK revenue was £33.75 b in FY, 2019 which is a 9.5% year over year increase from the previous period.

Embed Graph

GSK Revenue Breakdown

Embed Graph

GSK revenue breakdown by business segment: 26.7% from Consumer Healthcare, 21.2% from Vaccines and 52.1% from Global Pharmaceuticals

GSK revenue breakdown by geographic segment: 23.9% from Europe, 34.9% from International and 41.2% from US

GSK Income Statement

GSK Balance Sheet

Annual

GBPFY, 2016FY, 2017FY, 2018FY, 2019

Cash

4.9b3.8b3.9b4.7b

Accounts Receivable

4.6b4.7b5.2b5.5b

Inventories

5.1b5.6b5.5b5.9b

Current Assets

16.7b15.9b16.9b19.5b

PP&E

10.8b10.9b11.1b10.3b

Goodwill

6.0b5.7b5.8b10.6b

Total Assets

59.1b56.4b58.1b79.7b

Accounts Payable

3.6b3.5b3.6b4.1b

Short-term debt

4.1b2.8b5.8b6.9b

Current Liabilities

19.0b26.6b22.5b24.1b

Long-term debt

14.7b14.3b20.3b23.6b

Non-Current Liabilities

35.1b26.3b31.9b37.3b

Total Debt

18.8b17.1b26.1b30.5b

Total Liabilities

54.1b52.9b54.4b61.3b

Common Stock

1.3b1.3b1.3b1.3b

Additional Paid-in Capital

3.0b3.0b3.1b3.2b

Retained Earnings

(5.4b)(6.5b)(2.1b)4.5b

Total Equity

5.0b3.5b4.4b18.4b

Debt to Equity Ratio

3.8 x4.9 x6 x1.7 x

Debt to Assets Ratio

0.3 x0.3 x0.4 x0.4 x

Financial Leverage

11.9 x16.2 x13.3 x4.3 x

GSK Cash Flow

Annual

GBPFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

1.1b2.2b4.0b5.3b

Depreciation and Amortization

1.6b1.9b1.9b2.3b

Accounts Receivable

(188.0m)(287.0m)(984.0m)(32.0m)

Inventories

70.0m(461.0m)51.0m300.0m

Accounts Payable

96.0m11.0m131.0m263.0m

Cash From Operating Activities

6.5b6.9b8.4b8.0b

Purchases of PP&E

(1.5b)(1.5b)(1.3b)(1.3b)

Cash From Investing Activities

(1.3b)(1.4b)(1.6b)(5.4b)

Short-term Borrowings

(919.0m)(3.2b)(2.0b)(4.2b)

Long-term Borrowings

(18.0m)(23.0m)(28.0m)(214.0m)

Dividends Paid

(4.8b)(3.9b)(3.9b)(4.3b)

Cash From Financing Activities

(6.4b)(6.4b)(6.4b)(1.8b)

Net Change in Cash

(1.2b)(905.0m)479.0m826.0m

Interest Paid

732.0m781.0m766.0m895.0m

Income Taxes Paid

1.6b1.3b1.3b1.5b

GSK Ratios

GBPFY, 2016

EV/EBIT

41.4 x

EV/CFO

16.6 x

Revenue/Employee

280.9k

Debt/Equity

3.8 x

Debt/Assets

0.3 x

Financial Leverage

11.9 x

P/E Ratio

206.7

GSK Operating Metrics

FY, 2016FY, 2017FY, 2018FY, 2019

Volume of Medicines Produced

2 b1.9 b2.3 b2.3 b

Vaccines

833 m798 m770 m701 m

Consumer Healthcare Products Produced

5 b6.2 b3.8 b4.2 b

Vaccine Doses Delivered per Day

2 m2 m2 m2 m

Healthcare Products in Development

4639

Manufacturing Facilities

87

Markets

150

New Product Launches

30

Partners

1.5 k2 k

Phase I Trials Products

1712

Phase III Trials Products

1814

Phase III Trials Products (Haemophilia)

1116

GSK Sustainability Metrics

 FY, 2019

Water Used (Tankers)

180 k cubic meters

Water Used (Municipal)

8.8 m cubic meters

Water Used (Groundwater)

3.38 m cubic meters

Water Used

12.37 m cubic meters

Wastewater Discharged

9.9 m cubic meters

Waste Generated

117 k tonnes

Total Recordable Incident Rate

0.22

Total Energy Used

4 m MWh

Number of Fatalities

1

Nonhazardous Waste (Landfilled)

2.9 k tonnes

Lost Time Incident Rate

0.14

Lost Time Accidents

289

Hazardous Waste (Landfilled)

100 tonnes

Greenhouse Gas Emissions (Scope 2)

523 k metric tons of carbon dioxide equivalent

Greenhouse Gas Emissions (Scope 1)

800 k metric tons of carbon dioxide equivalent

Greenhouse Gas Emissions (Scope 1 and Scope 2)

1.32 m metric tons of carbon dioxide equivalent

Energy Used from Renewable Energy Sources (Purchased)

51 k MWh

Energy Used from Renewable Energy Sources (On-Site Renewable Energy)

25 k MWh

Energy Used (Steam)

52 k MWh

Energy Used (Purchased Electricity)

1.54 m MWh

Energy Used (Natural Gas)

1.99 m MWh

Energy Used (Fuel and Other)

92 k MWh

Energy Used (Electricity)

1.55 m MWh

Energy Used (Coal)

63 k MWh

Energy Used (Biomass)

237 k MWh

Electricity Used from Renewable Energy Sources, percent

5%

Diversion Rate

79%

GSK Human Capital

GSK's employees are reported to be approximately 45% female and 55% male.
FY, 2019FY, 2018FY, 2017FY, 2016
Selling39.4%38.1%38%38.4%
Manufacturing37.1%38.3%38.8%38.6%
Research and Development12.1%12.4%11.7%11.6%
Administration11.3%11.3%11.5%11.3%
FY, 2019FY, 2018FY, 2017FY, 2016
Female45%44.9%44%43.5%
Male55%55.1%56%56.5%

GSK Employee Rating

3.87785 votes
Culture & Values
4
Work/Life Balance
3.9
Senior Management
3.5
Salary & Benefits
4
Career Opportunities
3.6
Source